Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
C. Esquinas (barcelona, Spain), I. Belmonte (barcelona, Spain), A. Gonzalez (barcelona, Spain), M. Barrecheguren (barcelona, Spain), A. Nuñez (barcelona, Spain), M. Sarasate (barcelona, Spain), E. Loeb (barcelona, Spain), E. Rodriguez (barcelona, Spain), F. Rodriguez-Frias (barcelona, Spain), M. Miravitlles (barcelona, Spain). Structural and clinical characterization of novel missense variants of SERPINA1 gene causing alpha-1 antitrypsin deficiency. 5414

Member's Comments

No comment yet.

Related content which might interest you: A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis. Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Identification and analysis of rare and novel mutations of the alpha-1-antitrypsin gene Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Alpha-1 antitrypsin: functional analysis of novel variants Source: Research Seminar 2014 - Protein quality control in lung disease Year: 2014 Identification and characterisation of twenty-two novel SERPINA1 pathological mutations Source: Virtual Congress 2020 – Genetic and environmental influences on development of asthma and COPD Year: 2020 PiS and PiS-plus alleles. The importance of phasing gene variants in Alpha-1 Antitrypsin Deficiency Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 a1-antitrypsin PI*SZ genotype: a SERPINA1 deficiency haplotype with uncertain clinical and therapeutic implications Source: Eur Respir J, 55 (6) 2000713; 10.1183/13993003.00713-2020 Year: 2020 Rare SERPINA1 allele Mwhitstable in patients with Alpha1-antitrypsin deficiency Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 384s Year: 2003 Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Identification and characterisation of seven novel SERPINA1 null mutations Source: International Congress 2014 – Genes and environment in asthma and COPD Year: 2014 SERPINA1 gene variants in subjects from a general population with reduced alpha1-antitrypsin level Source: Annual Congress 2008 - COPD Year: 2008 microRNA regulation of the alpha-1 antitrypsin gene Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Prevalence and phenotype of subjects carrying rare variants in Argentina for alpha1-antitrypsin deficiency Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold Source: Eur Respir J, 59 (2) 2101410; 10.1183/13993003.01410-2021 Year: 2022